Hi all! I write the summary of important clinical studies in hematology and oncology every week! Check out the collection here so far and subscribe to get them delivered to your inbox every Wednesday! asthathakkar.substack.com/?utm_source=tw…

Landmark clinical studies in Hematology/Oncology: The DESTINY of Trastuzumab Deruxtecan asthathakkar.substack.com/p/the-destiny-…

Excited for IASLC #TTLC23 #TTLC2023 to hear the latest on 🫁 #LCSM! Hem-Onc Fellows Network, prepare for the meeting with #studyguide for #NSCLC treatment! ⬇️ #clinicaltrials are imp to consider! #NotMedicalAdvice #InputsWelcome 🙏 OncoAlert Mayo Clinic Hematology-Oncology Fellowship Matthew Ho ASCO OncMedEdCoP

Landmark clinical studies in Hematology/Oncology: CLIMBING the HER2 ladder asthathakkar.substack.com/p/climbing-the…

Landmark clinical studies in Hematology/Oncology: Pembrolizumab in metastatic non-small cell lung cancer asthathakkar.substack.com/p/pembrolizuma…

Hello March! This month I am focusing on summarizing important clinical trials pertaining to NSCLC. Check it out! asthathakkar.substack.com/?utm_source=tw…

Landmark clinical studies in Hematology/Oncology: Pembrolizumab plus chemotherapy in NSCLC asthathakkar.substack.com/p/pembrolizuma…

Landmark clinical studies in Hematology/Oncology: Durvalumab in Stage III NSCLC asthathakkar.substack.com/p/durvalumab-i…

Landmark clinical studies in Hematology/Oncology: Adjuvant atezolizumab in NSCLC asthathakkar.substack.com/p/adjuvant-ate…

Landmark clinical studies in Hematology/Oncology: Neoadjuvant nivolumab in resectable NSCLC asthathakkar.substack.com/p/neoadjuvant-…

Landmark clinical studies in Hematology/Oncology: Anti-BCMA CAR-T in multiple myeloma asthathakkar.substack.com/p/anti-bcma-ca…

I have a serious question for all the #women #physicians out there. What is your favorite footwear to wear in the hospital? One that is comfortable and doesn’t give bunions? @WIMSummit Hematology & Oncology Women Physicians Group—HOWPG Women in Oncology